Skip to main content
Top
Published in: Journal of General Internal Medicine 11/2017

01-11-2017 | Review Paper

Elements of Program Design in Medicare’s Value-based and Alternative Payment Models: a Narrative Review

Authors: Karen E. Joynt Maddox, MD, MPH, Aditi P. Sen, PhD, Lok Wong Samson, PhD, Rachael B. Zuckerman, PhD, Nancy DeLew, MA, MAPA, Arnold M. Epstein, MD, MA

Published in: Journal of General Internal Medicine | Issue 11/2017

Login to get access

Abstract

Increasing emphasis on value in health care has spurred the development of value-based and alternative payment models. Inherent in these models are choices around program scope (broad vs. narrow); selecting absolute or relative performance targets; rewarding improvement, achievement, or both; and offering penalties, rewards, or both. We examined and classified current Medicare payment models—the Hospital Readmissions Reduction Program (HRRP), Hospital Value-Based Purchasing Program (HVBP), Hospital-Acquired Conditions Reduction Program (HACRP), Medicare Advantage Quality Star Rating program, Physician Value-Based Payment Modifier (VM) and its successor, the Merit-Based Incentive Payment System (MIPS), and the Medicare Shared Savings Program (MSSP) on these elements of program design and reviewed the literature to place findings in context. We found that current Medicare payment models vary significantly across each parameter of program design examined. For example, in terms of scope, the HRRP focuses exclusively on risk-standardized excess readmissions and the HACRP on patient safety. In contrast, HVBP includes 21 measures in five domains, including both quality and cost measures. Choices regarding penalties versus bonuses are similarly variable: HRRP and HACRP are penalty-only; HVBP, VM, and MIPS are penalty-or-bonus; and the MSSP and MA quality star rating programs are largely bonus-only. Each choice has distinct pros and cons that impact program efficacy. Unfortunately, there are scant data to inform which program design choice is best. While no one approach is clearly superior to another, the variability contained within these programs provides an important opportunity for Medicare and others to learn from these undertakings and to use that knowledge to inform future policymaking.
Literature
1.
go back to reference Burwell SM. Setting value-based payment goals—HHS efforts to improve US health care. N Engl J Med. 2015;372(10):897–9.CrossRefPubMed Burwell SM. Setting value-based payment goals—HHS efforts to improve US health care. N Engl J Med. 2015;372(10):897–9.CrossRefPubMed
2.
go back to reference Rosenthal MB, Dudley RA. Pay-for-performance: will the latest payment trend improve care? JAMA. 2007;297(7):740–4.CrossRefPubMed Rosenthal MB, Dudley RA. Pay-for-performance: will the latest payment trend improve care? JAMA. 2007;297(7):740–4.CrossRefPubMed
3.
go back to reference Centers for Medicare and Medicaid Services. FY 2013 IPPS Final Rule: Hospital Readmissions Reduction Program. Baltimore, MD: Centers for Medicare and Medicaid Services; 2012. Centers for Medicare and Medicaid Services. FY 2013 IPPS Final Rule: Hospital Readmissions Reduction Program. Baltimore, MD: Centers for Medicare and Medicaid Services; 2012.
4.
go back to reference Centers for Medicare and Medicaid Services. Hospital Value-Based Purchasing: The Official Website for the Medicare Hospital Value-based Purchasing Program. Vol. 2014; 2014. Centers for Medicare and Medicaid Services. Hospital Value-Based Purchasing: The Official Website for the Medicare Hospital Value-based Purchasing Program. Vol. 2014; 2014.
5.
go back to reference Centers for Medicare and Medicaid Services. Hospital-Acquired Condition (HAC) Reduction Program. Vol. 2015. Baltimore, MD: Centers for Medicare and Medicaid Services; 2014. Centers for Medicare and Medicaid Services. Hospital-Acquired Condition (HAC) Reduction Program. Vol. 2015. Baltimore, MD: Centers for Medicare and Medicaid Services; 2014.
6.
go back to reference US Department of Health & Human Services. Star Ratings. Vol. 2016; 2016. US Department of Health & Human Services. Star Ratings. Vol. 2016; 2016.
7.
go back to reference Centers for Medicare and Medicaid Services. Medicare FFS Physician Feedback Program/Value-Based Payment Modifier. Vol. 2014; 2014. Centers for Medicare and Medicaid Services. Medicare FFS Physician Feedback Program/Value-Based Payment Modifier. Vol. 2014; 2014.
8.
go back to reference Centers for Medicare and Medicaid Services. Quality Payment Program: Delivery System Reform, Medicare Payment Reform, & MACRA. Vol. 2016; 2016. Centers for Medicare and Medicaid Services. Quality Payment Program: Delivery System Reform, Medicare Payment Reform, & MACRA. Vol. 2016; 2016.
9.
go back to reference Centers for Medicare and Medicaid Services. Shared Savings Program. Vol. 2014. Baltimore, MD: Centers for Medicare and Medicaid Services; 2014. Centers for Medicare and Medicaid Services. Shared Savings Program. Vol. 2014. Baltimore, MD: Centers for Medicare and Medicaid Services; 2014.
10.
go back to reference Gillam SJ, Siriwardena AN, Steel N. Pay-for-performance in the United Kingdom: impact of the quality and outcomes framework: a systematic review. Ann Fam Med. 2012;10(5):461–8.CrossRefPubMedPubMedCentral Gillam SJ, Siriwardena AN, Steel N. Pay-for-performance in the United Kingdom: impact of the quality and outcomes framework: a systematic review. Ann Fam Med. 2012;10(5):461–8.CrossRefPubMedPubMedCentral
11.
go back to reference Figueroa JF, Tsugawa Y, Zheng J, Orav EJ, Jha AK. Association between the Value-Based Purchasing pay for performance program and patient mortality in US hospitals: observational study. BMJ. 2016;353:i2214.CrossRefPubMedPubMedCentral Figueroa JF, Tsugawa Y, Zheng J, Orav EJ, Jha AK. Association between the Value-Based Purchasing pay for performance program and patient mortality in US hospitals: observational study. BMJ. 2016;353:i2214.CrossRefPubMedPubMedCentral
12.
go back to reference Zuckerman RB, Sheingold SH, Orav EJ, Ruhter J, Epstein AM. Readmissions, Observation, and the Hospital Readmissions Reduction Program. N Engl J Med. 2016. Zuckerman RB, Sheingold SH, Orav EJ, Ruhter J, Epstein AM. Readmissions, Observation, and the Hospital Readmissions Reduction Program. N Engl J Med. 2016.
13.
go back to reference Wasfy JH, Zigler CM, Choirat C, Wang Y, Dominici F, Yeh RW. Readmission Rates After Passage of the Hospital Readmissions Reduction Program: A Pre-Post Analysis. Ann Intern Med. 2016. Wasfy JH, Zigler CM, Choirat C, Wang Y, Dominici F, Yeh RW. Readmission Rates After Passage of the Hospital Readmissions Reduction Program: A Pre-Post Analysis. Ann Intern Med. 2016.
14.
go back to reference Desai NR, Ross JS, Kwon JY, et al. Association Between Hospital Penalty Status Under the Hospital Readmission Reduction Program and Readmission Rates for Target and Nontarget Conditions. JAMA. 2016;316(24):2647–2656.CrossRefPubMedPubMedCentral Desai NR, Ross JS, Kwon JY, et al. Association Between Hospital Penalty Status Under the Hospital Readmission Reduction Program and Readmission Rates for Target and Nontarget Conditions. JAMA. 2016;316(24):2647–2656.CrossRefPubMedPubMedCentral
15.
go back to reference Doran T, Kontopantelis E, Valderas JM, et al. Effect of financial incentives on incentivised and non-incentivised clinical activities: longitudinal analysis of data from the UK Quality and Outcomes Framework. BMJ. 2011;342:d3590.CrossRefPubMedPubMedCentral Doran T, Kontopantelis E, Valderas JM, et al. Effect of financial incentives on incentivised and non-incentivised clinical activities: longitudinal analysis of data from the UK Quality and Outcomes Framework. BMJ. 2011;342:d3590.CrossRefPubMedPubMedCentral
16.
go back to reference Kontopantelis E, Springate D, Reeves D, Ashcroft DM, Valderas JM, Doran T. Withdrawing performance indicators: retrospective analysis of general practice performance under UK Quality and Outcomes Framework. BMJ. 2014;348:g330.CrossRefPubMedPubMedCentral Kontopantelis E, Springate D, Reeves D, Ashcroft DM, Valderas JM, Doran T. Withdrawing performance indicators: retrospective analysis of general practice performance under UK Quality and Outcomes Framework. BMJ. 2014;348:g330.CrossRefPubMedPubMedCentral
17.
go back to reference Benzer JK, Young GJ, Burgess JF, Jr., et al. Sustainability of quality improvement following removal of pay-for-performance incentives. J Gen Intern Med. 2014;29(1):127–32.CrossRefPubMed Benzer JK, Young GJ, Burgess JF, Jr., et al. Sustainability of quality improvement following removal of pay-for-performance incentives. J Gen Intern Med. 2014;29(1):127–32.CrossRefPubMed
18.
go back to reference Rosenthal MB, Frank RG, Li Z, Epstein AM. Early experience with pay-for-performance: from concept to practice. JAMA. 2005;294(14):1788–93.CrossRefPubMed Rosenthal MB, Frank RG, Li Z, Epstein AM. Early experience with pay-for-performance: from concept to practice. JAMA. 2005;294(14):1788–93.CrossRefPubMed
19.
go back to reference McWilliams JM, Hatfield LA, Chernew ME, Landon BE, Schwartz AL. Early performance of accountable care organizations in Medicare. N Engl J Med. 2016;374(24):2357–66.CrossRefPubMedPubMedCentral McWilliams JM, Hatfield LA, Chernew ME, Landon BE, Schwartz AL. Early performance of accountable care organizations in Medicare. N Engl J Med. 2016;374(24):2357–66.CrossRefPubMedPubMedCentral
20.
go back to reference McWilliams JM, Chernew ME, Landon BE, Schwartz AL. Performance differences in year 1 of pioneer accountable care organizations. N Engl J Med. 2015;372(20):1927–36.CrossRefPubMedPubMedCentral McWilliams JM, Chernew ME, Landon BE, Schwartz AL. Performance differences in year 1 of pioneer accountable care organizations. N Engl J Med. 2015;372(20):1927–36.CrossRefPubMedPubMedCentral
21.
go back to reference Joynt KE, Jha AK. Characteristics of hospitals receiving penalties under the Hospital Readmissions Reduction Program. JAMA. 2013;309(4):342–3.CrossRefPubMed Joynt KE, Jha AK. Characteristics of hospitals receiving penalties under the Hospital Readmissions Reduction Program. JAMA. 2013;309(4):342–3.CrossRefPubMed
22.
go back to reference Gilman M, Hockenberry JM, Adams EK, Milstein AS, Wilson IB, Becker ER. The financial effect of value-based purchasing and the Hospital Readmissions Reduction Program on Safety-Net Hospitals in 2014: a cohort study. Ann Intern Med. 2015;163(6):427–36.CrossRefPubMed Gilman M, Hockenberry JM, Adams EK, Milstein AS, Wilson IB, Becker ER. The financial effect of value-based purchasing and the Hospital Readmissions Reduction Program on Safety-Net Hospitals in 2014: a cohort study. Ann Intern Med. 2015;163(6):427–36.CrossRefPubMed
23.
go back to reference Rajaram R, Chung JW, Kinnier CV, et al. Hospital characteristics associated with penalties in the Centers for Medicare & Medicaid Services Hospital-Acquired Condition Reduction Program. JAMA. 2015;314(4):375–83.CrossRefPubMed Rajaram R, Chung JW, Kinnier CV, et al. Hospital characteristics associated with penalties in the Centers for Medicare & Medicaid Services Hospital-Acquired Condition Reduction Program. JAMA. 2015;314(4):375–83.CrossRefPubMed
24.
go back to reference Weiss H, Pescatello S. Medicare Advantage: Stars System’s disproportionate impact on MA plans focusing on low-income populations. Health Affairs Blog. Vol. 2014: Health Affairs; 2014. Weiss H, Pescatello S. Medicare Advantage: Stars System’s disproportionate impact on MA plans focusing on low-income populations. Health Affairs Blog. Vol. 2014: Health Affairs; 2014.
25.
go back to reference Mukamel DB, Mushlin AI. Quality of care information makes a difference: an analysis of market share and price changes after publication of the New York State Cardiac Surgery Mortality Reports. Med Care. 1998;36(7):945–54.CrossRefPubMed Mukamel DB, Mushlin AI. Quality of care information makes a difference: an analysis of market share and price changes after publication of the New York State Cardiac Surgery Mortality Reports. Med Care. 1998;36(7):945–54.CrossRefPubMed
26.
go back to reference Wang J, Hockenberry J, Chou SY, Yang M. Do bad report cards have consequences? Impacts of publicly reported provider quality information on the CABG market in Pennsylvania. J Health Econ. 2011;30(2):392–407.CrossRefPubMed Wang J, Hockenberry J, Chou SY, Yang M. Do bad report cards have consequences? Impacts of publicly reported provider quality information on the CABG market in Pennsylvania. J Health Econ. 2011;30(2):392–407.CrossRefPubMed
27.
go back to reference Chen TT, Lai MS, Chung KP. Participating physician preferences regarding a pay-for-performance incentive design: a discrete choice experiment. Int J Qual Health Care. 2016;28(1):40–6.CrossRefPubMed Chen TT, Lai MS, Chung KP. Participating physician preferences regarding a pay-for-performance incentive design: a discrete choice experiment. Int J Qual Health Care. 2016;28(1):40–6.CrossRefPubMed
28.
go back to reference Landon BE, O’Malley AJ, McKellar MR, Reschovsky JD, Hadley J. Physician compensation strategies and quality of care for Medicare beneficiaries. Am J Manag Care. 2014;20(10):804–11.PubMed Landon BE, O’Malley AJ, McKellar MR, Reschovsky JD, Hadley J. Physician compensation strategies and quality of care for Medicare beneficiaries. Am J Manag Care. 2014;20(10):804–11.PubMed
29.
go back to reference Lee TH, Bothe A, Steele GD. How Geisinger structures its physicians’ compensation to support improvements in quality, efficiency, and volume. Health Aff (Millwood). 2012;31(9):2068–73.CrossRefPubMed Lee TH, Bothe A, Steele GD. How Geisinger structures its physicians’ compensation to support improvements in quality, efficiency, and volume. Health Aff (Millwood). 2012;31(9):2068–73.CrossRefPubMed
30.
go back to reference Kahneman DT, Amos. Choices, values, and frames. New York; Cambridge, UK: Russell Sage Foundation; Cambridge University Press; 2000. Kahneman DT, Amos. Choices, values, and frames. New York; Cambridge, UK: Russell Sage Foundation; Cambridge University Press; 2000.
31.
go back to reference O’Brien BJ, Gertsen K, Willan AR, Faulkner LA. Is there a kink in consumers’ threshold value for cost-effectiveness in health care? Health Econ. 2002;11(2):175–80.CrossRefPubMed O’Brien BJ, Gertsen K, Willan AR, Faulkner LA. Is there a kink in consumers’ threshold value for cost-effectiveness in health care? Health Econ. 2002;11(2):175–80.CrossRefPubMed
32.
go back to reference Torchiana DF, Colton DG, Rao SK, Lenz SK, Meyer GS, Ferris TG. Massachusetts General Physicians Organization’s quality incentive program produces encouraging results. Health Aff (Millwood). 2013;32(10):1748–56.CrossRefPubMed Torchiana DF, Colton DG, Rao SK, Lenz SK, Meyer GS, Ferris TG. Massachusetts General Physicians Organization’s quality incentive program produces encouraging results. Health Aff (Millwood). 2013;32(10):1748–56.CrossRefPubMed
33.
go back to reference Custers T, Hurley J, Klazinga NS, Brown AD. Selecting effective incentive structures in health care: A decision framework to support health care purchasers in finding the right incentives to drive performance. BMC Health Serv Res. 2008;8(1):1–14. Custers T, Hurley J, Klazinga NS, Brown AD. Selecting effective incentive structures in health care: A decision framework to support health care purchasers in finding the right incentives to drive performance. BMC Health Serv Res. 2008;8(1):1–14.
34.
go back to reference Halpern SD, Kohn R, Dornbrand-Lo A, Metkus T, Asch DA, Volpp KG. Lottery-based versus fixed incentives to increase clinicians’ response to surveys. Health Serv Res. 2011;46(5):1663–74.CrossRefPubMedPubMedCentral Halpern SD, Kohn R, Dornbrand-Lo A, Metkus T, Asch DA, Volpp KG. Lottery-based versus fixed incentives to increase clinicians’ response to surveys. Health Serv Res. 2011;46(5):1663–74.CrossRefPubMedPubMedCentral
35.
go back to reference Kimmel SE, Troxel AB, French B, et al. A randomized trial of lottery-based incentives and reminders to improve warfarin adherence: the Warfarin Incentives (WIN2) Trial. Pharmacoepidemiol Drug Saf. 2016. Kimmel SE, Troxel AB, French B, et al. A randomized trial of lottery-based incentives and reminders to improve warfarin adherence: the Warfarin Incentives (WIN2) Trial. Pharmacoepidemiol Drug Saf. 2016.
36.
go back to reference Kimmel SE, Troxel AB, Loewenstein G, et al. Randomized trial of lottery-based incentives to improve warfarin adherence. Am Heart J. 2012;164(2):268–74.CrossRefPubMedPubMedCentral Kimmel SE, Troxel AB, Loewenstein G, et al. Randomized trial of lottery-based incentives to improve warfarin adherence. Am Heart J. 2012;164(2):268–74.CrossRefPubMedPubMedCentral
37.
go back to reference Ryan AM, Burgess JF, Jr, Pesko MF, Borden WB, Dimick JB. The early effects of Medicare’s Mandatory Hospital Pay-for-Performance Program. Health Serv Res. 2014. Ryan AM, Burgess JF, Jr, Pesko MF, Borden WB, Dimick JB. The early effects of Medicare’s Mandatory Hospital Pay-for-Performance Program. Health Serv Res. 2014.
38.
go back to reference Sutton M, Nikolova S, Boaden R, Lester H, McDonald R, Roland M. Reduced mortality with hospital pay for performance in England. N Engl J Med. 2012;367(19):1821–8.CrossRefPubMed Sutton M, Nikolova S, Boaden R, Lester H, McDonald R, Roland M. Reduced mortality with hospital pay for performance in England. N Engl J Med. 2012;367(19):1821–8.CrossRefPubMed
39.
go back to reference Jha AK, Joynt KE, Orav EJ, Epstein AM. The long-term effect of premier pay for performance on patient outcomes. N Engl J Med. 2012;366(17):1606–15.CrossRefPubMed Jha AK, Joynt KE, Orav EJ, Epstein AM. The long-term effect of premier pay for performance on patient outcomes. N Engl J Med. 2012;366(17):1606–15.CrossRefPubMed
40.
go back to reference Hickson GB, Altemeier WA, Perrin JM. Physician reimbursement by salary or fee-for-service: effect on physician practice behavior in a randomized prospective study. Pediatrics. 1987;80(3):344–50.PubMed Hickson GB, Altemeier WA, Perrin JM. Physician reimbursement by salary or fee-for-service: effect on physician practice behavior in a randomized prospective study. Pediatrics. 1987;80(3):344–50.PubMed
42.
go back to reference Sanghavi DM, Conway PH. Paying for prevention: a novel test of Medicare value-based payment for cardiovascular risk reduction. JAMA. 2015;314(2):123–4.CrossRefPubMed Sanghavi DM, Conway PH. Paying for prevention: a novel test of Medicare value-based payment for cardiovascular risk reduction. JAMA. 2015;314(2):123–4.CrossRefPubMed
43.
go back to reference Centers for Medicare and Medicaid Services. Home Health Value-Based Purchasing Model. Vol. 2016; 2016. Centers for Medicare and Medicaid Services. Home Health Value-Based Purchasing Model. Vol. 2016; 2016.
Metadata
Title
Elements of Program Design in Medicare’s Value-based and Alternative Payment Models: a Narrative Review
Authors
Karen E. Joynt Maddox, MD, MPH
Aditi P. Sen, PhD
Lok Wong Samson, PhD
Rachael B. Zuckerman, PhD
Nancy DeLew, MA, MAPA
Arnold M. Epstein, MD, MA
Publication date
01-11-2017
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 11/2017
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-017-4125-8

Other articles of this Issue 11/2017

Journal of General Internal Medicine 11/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.